# A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir

> **NCT00148785** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 15 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Indinavir/Ritonavir/Fosamprenavir

## Key facts

- **NCT ID:** NCT00148785
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2013-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148785, "A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00148785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*